Saranacentral Bajatama Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Saranacentral Bajatama Tbk trades at Rp161 (market cap 288B, 1.21M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Saranacentral Bajatama Tbk is the larger of the two by market cap, and Saranacentral Bajatama Tbk is more actively traded (1.21M versus 214.9K). Which is the better fit depends on your goals.
| BAJA | OBAT | |
|---|---|---|
Market Cap | 288B | 164.65B |
Volume | 1.21M | 214.9K |
Lot | 12.09K | 2.15K |
Turnover | 193.62M | 51.97M |
Average Price | 160.18 | 241.85 |
Value | 193.62M | 51.97M |
Indicative Equilibrium Price | 161 | 240 |
Indicative Equilibrium Volume | 4 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Saranacentral Bajatama (SCB), established in 1996, is belonging to Sarana Steel Group, which was set up in 1970 and has built up its strong reputation in the worldwide steel industry. In order to provide competitive Hot-Dip Galvanized Steel Sheet/Coil to the customers, SCB take advantage of more advanced NOF (Non-Oxidation Furnace) System for production process, by which SCB differentiate itself from other competitors that use conventional processing system.
Read more on BAJA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →